← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neurokine Therapeutics, Llc
New York City, NY
$6,048,776
Total funding
2
Grants
Funding over time
peak $2M · FY2018–23$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,048,776 · 2
By mechanism
R42$3,155,525 · 1
R44$2,893,251 · 1
Investigators at Neurokine Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate$2,018,653
R42 · FY2019 · AG
Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia$1,218,076
R44 · FY2023 · AG
Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia$1,175,175
R44 · FY2021 · AG
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate$631,965
R42 · FY2020 · AG
Production and quality analysis of clinical drug for a novel CNS protein kinase inhibitor therapeutic candidate$504,907
R42 · FY2018 · AG
Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia$500,000
R44 · FY2020 · AG